Scientific article

Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole

Published inScandinavian journal of infectious diseases, vol. 34, no. 9, p. 701-703
Publication date2002

Paecilomyces lilacinus is a rare cause of endophthalmitis and there are few reports of it in the literature. Herein we report a patient with P. lilacinus endophthalmitis who was treated with the new triazole, voriconazole, for 4 months, with a good clinical evolution. This treatment appears to be a valuable new therapeutic option but requires further clinical confirmation.

  • Adolescent
  • Adult
  • Aged
  • Antifungal Agents/ therapeutic use
  • Endophthalmitis/ drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mycoses/ drug therapy
  • Paecilomyces/ isolation & purification
  • Pyrimidines/ therapeutic use
  • Triazoles/ therapeutic use
Citation (ISO format)
GARBINO, Jorge et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. In: Scandinavian journal of infectious diseases, 2002, vol. 34, n° 9, p. 701–703.
Updates (1)
ISSN of the journal0036-5548

Technical informations

Creation06/21/2010 10:24:19 AM
First validation06/21/2010 10:24:19 AM
Update time03/14/2023 3:43:44 PM
Status update03/14/2023 3:43:44 PM
Last indexation08/28/2023 6:14:00 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack